{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:04Z","timestamp":1787496964052,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dysfunctional polymorphisms of Fc\u03b3RIIb, an inhibitory receptor, are associated with Systemic Lupus Erythaematosus (SLE). Cryptococcosis is an invasive fungal infection in SLE, perhaps due to the de novo immune defect. We investigated cryptococcosis in the Fc\u03b3RIIb\u2212\/\u2212 mouse-lupus-model. Mortality, after intravenous\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    -induced cryptococcosis, in young (8-week-old) and older (24-week-old) Fc\u03b3RIIb\u2212\/\u2212 mice, was higher than in age-matched wild-types. Severe cryptococcosis in the Fc\u03b3RIIb\u2212\/\u2212 mice was demonstrated by high fungal burdens in the internal organs with histological cryptococcoma-like lesions and high levels of TNF-\u03b1 and IL-6, but not IL-10. Interestingly, Fc\u03b3RIIb\u2212\/\u2212 macrophages demonstrated more prominent phagocytosis but did not differ in killing activity\n                    <jats:italic>in vitro<\/jats:italic>\n                    and the striking TNF-\u03b1, IL-6 and IL-10 levels, compared to wild-type cells. Indeed,\n                    <jats:italic>in vivo<\/jats:italic>\n                    macrophage depletion with liposomal clodronate attenuated the fungal burdens in Fc\u03b3RIIb\u2212\/\u2212 mice, but not wild-type mice. When administered to wild-type mice, Fc\u03b3RIIb\u2212\/\u2212 macrophages with phagocytosed\n                    <jats:italic>Cryptococcus<\/jats:italic>\n                    resulted in higher fungal burdens than Fc\u03b3RIIb+\/+ macrophages with phagocytosed\n                    <jats:italic>Cryptococcus<\/jats:italic>\n                    . These results support, at least in part, a model whereby, in Fc\u03b3RIIb\u2212\/\u2212 mice, enhanced\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    transmigration occurs through infected macrophages. In summary, prominent phagocytosis, with limited effective killing activity, and high pro-inflammatory cytokine production by Fc\u03b3RIIb\u2212\/\u2212 macrophages were correlated with more severe cryptococcosis in Fc\u03b3RIIb\u2212\/\u2212 mice.\n                  <\/jats:p>","DOI":"10.1038\/srep40006","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T05:24:55Z","timestamp":1484112295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans"],"prefix":"10.1038","volume":"7","author":[{"given":"Saowapha","family":"Surawut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thunnicha","family":"Ondee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujittra","family":"Taratummarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanapat","family":"Palaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapaporn","family":"Pisitkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariya","family":"Chindamporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asada","family":"Leelahavanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"BFsrep40006_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N Engl J Med 365, 2110\u201321 (2011).","journal-title":"N Engl J Med"},{"key":"BFsrep40006_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","volume":"9","author":"JC Crispin","year":"2013","unstructured":"Crispin, J. C., Hedrich, C. M. & Tsokos, G. C. Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol 9, 476\u201384 (2013).","journal-title":"Nat Rev Rheumatol"},{"key":"BFsrep40006_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0161-5890(02)00036-6","volume":"38","author":"S Radaev","year":"2002","unstructured":"Radaev, S. & Sun, P. Recognition of immunoglobulins by Fcgamma receptors. Mol Immunol 38, 1073\u201383 (2002).","journal-title":"Mol Immunol"},{"key":"BFsrep40006_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.imlet.2005.11.023","volume":"104","author":"Z Bajtay","year":"2006","unstructured":"Bajtay, Z., Csomor, E., Sandor, N. & Erdei, A. Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol Lett 104, 46\u201352 (2006).","journal-title":"Immunol Lett"},{"key":"BFsrep40006_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","volume":"13","author":"S Bolland","year":"2000","unstructured":"Bolland, S. & Ravetch, J. V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277\u201385 (2000).","journal-title":"Immunity"},{"key":"BFsrep40006_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","volume":"24","author":"F Nimmerjahn","year":"2006","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Fcgamma receptors: old friends and new family members. Immunity 24, 19\u201328 (2006).","journal-title":"Immunity"},{"key":"BFsrep40006_CR7","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.4049\/jimmunol.180.5.3329","volume":"180","author":"PJ Maglione","year":"2008","unstructured":"Maglione, P. J., Xu, J., Casadevall, A. & Chan, J. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J Immunol 180, 3329\u201338 (2008).","journal-title":"J Immunol"},{"key":"BFsrep40006_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1084\/jem.20032197","volume":"199","author":"MR Clatworthy","year":"2004","unstructured":"Clatworthy, M. R. & Smith, K. G. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 199, 717\u201323 (2004).","journal-title":"J Exp Med"},{"key":"BFsrep40006_CR9","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.1073\/pnas.0608889104","volume":"104","author":"MR Clatworthy","year":"2007","unstructured":"Clatworthy, M. R. et al. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 104, 7169\u201374 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep40006_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/rheumatology\/kel343","volume":"46","author":"HS Chen","year":"2007","unstructured":"Chen, H. S., Tsai, W. P., Leu, H. S., Ho, H. H. & Liou, L. B. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford) 46, 539\u201344 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep40006_CR11","doi-asserted-by":"publisher","first-page":"e42439","DOI":"10.1371\/journal.pone.0042439","volume":"7","author":"XP Hu","year":"2012","unstructured":"Hu, X. P. et al. Association of Fcgamma receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients. PLoS One 7, e42439 (2012).","journal-title":"PLoS One"},{"key":"BFsrep40006_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1399-0039.2004.00142.x","volume":"63","author":"ZT Chu","year":"2004","unstructured":"Chu, Z. T. et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63, 21\u20137 (2004).","journal-title":"Tissue Antigens"},{"key":"BFsrep40006_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/acr.20683","volume":"64","author":"RW Jakes","year":"2012","unstructured":"Jakes, R. W. et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 64, 159\u201368 (2012).","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFsrep40006_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1034\/j.1399-0039.2003.00047.x","volume":"61","author":"U Siriboonrit","year":"2003","unstructured":"Siriboonrit, U. et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 61, 374\u201383 (2003).","journal-title":"Tissue Antigens"},{"key":"BFsrep40006_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/08916930500123926","volume":"38","author":"N Tsuchiya","year":"2005","unstructured":"Tsuchiya, N. & Kyogoku, C. Role of Fc gamma receptor IIb polymorphism in the genetic background of systemic lupus erythematosus: insights from Asia. Autoimmunity 38, 347\u201352 (2005).","journal-title":"Autoimmunity"},{"key":"BFsrep40006_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/EC.00039-10","volume":"9","author":"K Voelz","year":"2010","unstructured":"Voelz, K. & May, R. C. Cryptococcal interactions with the host immune system. Eukaryot Cell 9, 835\u201346 (2010).","journal-title":"Eukaryot Cell"},{"key":"BFsrep40006_CR17","first-page":"647","volume":"45","author":"A Meesing","year":"2014","unstructured":"Meesing, A. et al. Disseminated cryptococcosis in an HIV-seronegative pregnant woman with transient T-lymphocytopenia: a case report and review of the literature. Southeast Asian J Trop Med Public Health 45, 647\u201353 (2014).","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"BFsrep40006_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/yea.2997","volume":"31","author":"D Srikanta","year":"2014","unstructured":"Srikanta, D., Santiago-Tirado, F. H. & Doering, T. L. Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast 31, 47\u201360 (2014).","journal-title":"Yeast"},{"key":"BFsrep40006_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.femsyr.2004.04.004","volume":"5","author":"X Zhu","year":"2004","unstructured":"Zhu, X. & Williamson, P. R. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res 5, 1\u201310 (2004).","journal-title":"FEMS Yeast Res"},{"key":"BFsrep40006_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1128\/MCB.19.1.745","volume":"19","author":"JD Nosanchuk","year":"1999","unstructured":"Nosanchuk, J. D., Valadon, P., Feldmesser, M. & Casadevall, A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 19, 745\u201350 (1999).","journal-title":"Mol Cell Biol"},{"key":"BFsrep40006_CR21","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0140-6736(00)02356-4","volume":"355","author":"JD Nosanchuk","year":"2000","unstructured":"Nosanchuk, J. D., Rosas, A. L., Lee, S. C. & Casadevall, A. Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355, 2049\u201350 (2000).","journal-title":"Lancet"},{"key":"BFsrep40006_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","volume":"42","author":"A Casadevall","year":"1998","unstructured":"Casadevall, A. et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42, 1437\u201346 (1998).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep40006_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrmicro974","volume":"2","author":"A Casadevall","year":"2004","unstructured":"Casadevall, A., Dadachova, E. & Pirofski, L. A. Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2, 695\u2013703 (2004).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep40006_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/fmb.14.132","volume":"10","author":"S Rohatgi","year":"2015","unstructured":"Rohatgi, S. & Pirofski, L. A. Host immunity to Cryptococcus neoformans. Future Microbiol 10, 565\u201381 (2015).","journal-title":"Future Microbiol"},{"key":"BFsrep40006_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/08830180213274","volume":"21","author":"Y Koguchi","year":"2002","unstructured":"Koguchi, Y. & Kawakami, K. Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 21, 423\u201338 (2002).","journal-title":"Int Rev Immunol"},{"key":"BFsrep40006_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1574-695X.2011.00871.x","volume":"64","author":"R Garcia-Rodas","year":"2012","unstructured":"Garcia-Rodas, R. & Zaragoza, O. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans. FEMS Immunol Med Microbiol 64, 147\u201361 (2012).","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BFsrep40006_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","volume":"19","author":"JV Ravetch","year":"2001","unstructured":"Ravetch, J. V. & Bolland, S. IgG Fc receptors. Annu Rev Immunol 19, 275\u201390 (2001).","journal-title":"Annu Rev Immunol"},{"key":"BFsrep40006_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/IAI.01065-08","volume":"77","author":"C Charlier","year":"2009","unstructured":"Charlier, C. et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77, 120\u20137 (2009).","journal-title":"Infect Immun"},{"key":"BFsrep40006_CR29","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1128\/IAI.00587-07","volume":"75","author":"TB Kechichian","year":"2007","unstructured":"Kechichian, T. B., Shea, J. & Del Poeta, M. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun 75, 4792\u20138 (2007).","journal-title":"Infect Immun"},{"key":"BFsrep40006_CR30","unstructured":"Weaver, K. F. et al. Effect of Liposomal Clodronate-Dependent Depletion of Professional Antigen Presenting Cells on Numbers and Phenotype of Canine Cd4+Cd25+Foxp3+ Regulatory T Cells. J Vet Med Res 1 (2014)."},{"key":"BFsrep40006_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1365-2133.2010.10129.x","volume":"164","author":"NL Ward","year":"2011","unstructured":"Ward, N. L. et al. Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice. Br J Dermatol 164, 750\u20138 (2011).","journal-title":"Br J Dermatol"},{"key":"BFsrep40006_CR32","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.4049\/jimmunol.177.10.6842","volume":"177","author":"C Monari","year":"2006","unstructured":"Monari, C. et al. Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor. J Immunol 177, 6842\u201351 (2006).","journal-title":"J Immunol"},{"key":"BFsrep40006_CR33","doi-asserted-by":"publisher","first-page":"d136","DOI":"10.2741\/A270","volume":"3","author":"M Feldmesser","year":"1998","unstructured":"Feldmesser, M. & Casadevall, A. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection. Front Biosci 3, d136\u201351 (1998).","journal-title":"Front Biosci"},{"key":"BFsrep40006_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-61779-527-5_14","volume":"844","author":"AM Nicola","year":"2012","unstructured":"Nicola, A. M. & Casadevall, A. In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages. Methods Mol Biol 844, 189\u201397 (2012).","journal-title":"Methods Mol Biol"},{"key":"BFsrep40006_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0167-7012(01)00348-7","volume":"49","author":"AG Vonk","year":"2002","unstructured":"Vonk, A. G., Wieland, C. W., Netea, M. G. & Kullberg, B. J. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J Microbiol Methods 49, 55\u201362 (2002).","journal-title":"J Microbiol Methods"},{"key":"BFsrep40006_CR36","first-page":"387","volume":"48","author":"J Zaias","year":"2009","unstructured":"Zaias, J., Mineau, M., Cray, C., Yoon, D. & Altman, N. H. Reference values for serum proteins of common laboratory rodent strains. J Am Assoc Lab Anim Sci 48, 387\u201390 (2009).","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"BFsrep40006_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI9244","volume":"106","author":"M Mihara","year":"2000","unstructured":"Mihara, M. et al. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J Clin Invest 106, 91\u2013101 (2000).","journal-title":"J Clin Invest"},{"key":"BFsrep40006_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.molimm.2012.03.017","volume":"51","author":"N Boonyatecha","year":"2012","unstructured":"Boonyatecha, N., Sangphech, N., Wongchana, W., Kueanjinda, P. & Palaga, T. Involvement of Notch signaling pathway in regulating IL-12 expression via c-Rel in activated macrophages. Mol Immunol 51, 255\u201362 (2012).","journal-title":"Mol Immunol"},{"key":"BFsrep40006_CR39","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1128\/IAI.00341-08","volume":"76","author":"L Guillot","year":"2008","unstructured":"Guillot, L., Carroll, S. F., Homer, R. & Qureshi, S. T. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection. Infect Immun 76, 4745\u201356 (2008).","journal-title":"Infect Immun"},{"key":"BFsrep40006_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5483\/BMBRep.2014.47.2.088","volume":"47","author":"HS Lee","year":"2014","unstructured":"Lee, H. S. et al. Anti-oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicus in LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway. BMB Rep 47, 98\u2013103 (2014).","journal-title":"BMB Rep"},{"key":"BFsrep40006_CR41","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/JCI72950","volume":"124","author":"W Sabiiti","year":"2014","unstructured":"Sabiiti, W. et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J Clin Invest 124, 2000\u20138 (2014).","journal-title":"J Clin Invest"},{"key":"BFsrep40006_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1742-2094-10-71","volume":"10","author":"S Redlich","year":"2013","unstructured":"Redlich, S., Ribes, S., Schutze, S., Eiffert, H. & Nau, R. Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells. J Neuroinflammation 10, 71 (2013).","journal-title":"J Neuroinflammation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep40006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40006","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T19:50:25Z","timestamp":1671825025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep40006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,14]]}},"alternative-id":["BFsrep40006"],"URL":"https:\/\/doi.org\/10.1038\/srep40006","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]},"assertion":[{"value":"6 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40006"}}